Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults
- Status
- COMPLETED
- Phase
- PHASE4
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
- Status
- COMPLETED
- Phase
- PHASE4
German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
- Status
- COMPLETED
- Phase
- PHASE2
Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
- Status
- TERMINATED
- Phase
- PHASE2
LMBA02 Protocol for Patients With a Burkitt Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
- Status
- TERMINATED
- Phase
- PHASE1
Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
- Status
- WITHDRAWN
- Phase
- NA
A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone
- Status
- WITHDRAWN
- Phase
- PHASE2